Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Source filing unavailable
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | $19.54M | $13.66M |
| Net Income | -$45.10M | -$39.54M |
| EPS Diluted | -$0.74 | -$2.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
